ATE316978T1 - Ent-steroide als selektiv wirksame estrogene - Google Patents
Ent-steroide als selektiv wirksame estrogeneInfo
- Publication number
- ATE316978T1 ATE316978T1 AT00925219T AT00925219T ATE316978T1 AT E316978 T1 ATE316978 T1 AT E316978T1 AT 00925219 T AT00925219 T AT 00925219T AT 00925219 T AT00925219 T AT 00925219T AT E316978 T1 ATE316978 T1 AT E316978T1
- Authority
- AT
- Austria
- Prior art keywords
- steroids
- ent
- selectively effective
- estrogens
- effective estrogens
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19917930A DE19917930A1 (de) | 1999-04-15 | 1999-04-15 | Ent-Steroide als selektiv wirksame Estrogene |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE316978T1 true ATE316978T1 (de) | 2006-02-15 |
Family
ID=7905255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00925219T ATE316978T1 (de) | 1999-04-15 | 2000-04-17 | Ent-steroide als selektiv wirksame estrogene |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1169336B1 (de) |
JP (1) | JP2002542255A (de) |
AR (1) | AR023497A1 (de) |
AT (1) | ATE316978T1 (de) |
AU (1) | AU4401100A (de) |
CA (1) | CA2371972A1 (de) |
CO (1) | CO5180552A1 (de) |
DE (2) | DE19917930A1 (de) |
ES (1) | ES2258005T3 (de) |
PE (1) | PE20010042A1 (de) |
WO (1) | WO2000063228A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6350739B1 (en) | 1999-08-11 | 2002-02-26 | University Of Florida Resarch Foundation, Inc. | Methods of prevention and treatment of ischemic damage |
US6958327B1 (en) | 1999-11-02 | 2005-10-25 | Schering, Ag | 18 Norsteroids as selectively active estrogens |
PT1226155E (pt) * | 1999-11-02 | 2007-07-26 | Bayer Schering Pharma Ag | 18-nor-esteróides como estrogénios selectivamente activos |
DE10039199A1 (de) * | 2000-08-10 | 2002-02-21 | Schering Ag | Kombinationspräparate aus einem ERß selektiven Estrogen und einem SERM oder Antiestrogen |
GB0020498D0 (en) * | 2000-08-18 | 2000-10-11 | Sterix Ltd | Compound |
DE10048634A1 (de) * | 2000-09-27 | 2002-04-18 | Jenapharm Gmbh | 19-Nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21, 16alpha-Laktonring |
AU2002232509A1 (en) | 2000-11-03 | 2002-05-15 | Washington University | Estrone-derivatives having cytoprotective activity |
WO2002040032A2 (en) * | 2000-11-17 | 2002-05-23 | Washington University | Cytoprotective estrogen derivatives |
DE10151365A1 (de) | 2001-10-17 | 2003-04-30 | Schering Ag | 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten |
WO2002094276A1 (en) | 2001-05-18 | 2002-11-28 | Pantarhei Bioscience B.V. | Pharmaceutical composition for use in hormone replacement therapy |
DE60223795T2 (de) | 2001-05-23 | 2008-11-27 | Pantarhei Bioscience B.V. | Tetrahydroxyliertes Östrogen enthaltendes Arzneistoffverabreichungssystem zur Verwendung in der hormonalen Kontrazeption |
ATE449606T1 (de) | 2001-05-23 | 2009-12-15 | Pantarhei Bioscience Bv | Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption |
DE10151363A1 (de) * | 2001-10-17 | 2003-05-08 | Schering Ag | Somatotrope Therapie |
PT1446128E (pt) | 2001-11-15 | 2007-03-30 | Pantarhei Bioscience Bv | Utilização de compostos estrogénicos combinados com compostos progestagénicos na terapia hormonal de substituição |
EP1358882A1 (de) * | 2002-04-30 | 2003-11-05 | Schering Aktiengesellschaft | Verwendung von Prodrogue von Estriol sulfamate zur Behandlung von autoimmunischen Erkrankungen |
WO2003103685A1 (en) | 2002-06-11 | 2003-12-18 | Pantarhei Bioscience B.V. | A method of treating human skin and a skin care composition for use in such a method |
EP1511496B1 (de) | 2002-06-11 | 2006-09-27 | Pantarhei Bioscience B.V. | Methode zur behandlung oder prävention immunologischer erkrankungen und pharmazeutische zusammensetzung zur solchen anwendung |
SI1526856T1 (sl) | 2002-07-12 | 2008-04-30 | Pantarhei Bioscience Bv | Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka |
EP1468690B1 (de) * | 2003-03-27 | 2008-10-08 | Pantarhei Bioscience B.V. | Verwendung von Estrogenen zur Behandlung von Männerunfruchtbarkeit |
DE20321786U1 (de) * | 2003-04-17 | 2010-02-04 | Presearch Gmbh | Kombinationspräparat aus oralem Kontrazeptivum und Calcium/Vitamin D |
US8236785B2 (en) | 2007-01-08 | 2012-08-07 | Pantarhei Bioscience B.V. | Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method |
ES2310968B1 (es) * | 2007-06-25 | 2010-02-08 | Italfarmaco, S.A. | Uso de estriol en bajas dosis. |
CA2729635A1 (en) * | 2008-07-03 | 2010-01-07 | Ananth Srinivasan | Compounds and processes for production of radiopharmaceuticals |
ES2699445T3 (es) | 2013-03-13 | 2019-02-11 | Sage Therapeutics Inc | Esteroides neuroactivos y métodos de utilización de los mismos |
CN104926916B (zh) * | 2015-06-05 | 2016-08-24 | 郑祖兰 | 甾体化合物,含其药物组合物及其制备方法和应用 |
PL3436022T3 (pl) | 2016-04-01 | 2022-08-08 | Sage Therapeutics, Inc. | Oksysterole i sposoby ich stosowania |
US10752653B2 (en) | 2016-05-06 | 2020-08-25 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
SI3481846T1 (sl) | 2016-07-07 | 2021-11-30 | Sage Therapeutics, Inc. | 11-substituirani 24-hidroksisteroli za uporabo pri zdravljenju stanj, povezanih z NMDA |
ES2935057T3 (es) | 2016-09-30 | 2023-03-01 | Sage Therapeutics Inc | C7 oxisteroles sustituidos y estos compuestos para su uso como moduladores de la NMDA |
RU2019115112A (ru) | 2016-10-18 | 2020-11-24 | Сейдж Терапьютикс, Инк. | Оксистеролы и способы их применения |
WO2021058648A1 (en) | 2019-09-27 | 2021-04-01 | Basf Se | Process for the purification of phytosterol |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1453212A (fr) * | 1963-06-05 | 1966-06-03 | Roussel Uclaf | Dérivés stéroïdes et procédé de préparation |
GB1103871A (en) * | 1964-03-11 | 1968-02-21 | Emi Ltd | Improvements relating to magnetic matrix stores |
FR1509931A (fr) * | 1966-04-29 | 1968-01-19 | Roussel Uclaf | Procédé de préparation de composés cétoniques optiquement actifs et produits enrésultant |
DD235394A3 (de) * | 1968-08-30 | 1986-05-07 | Barnikol Oettler Kurt | Verfahren zur herstellung von oestradiol-3-methylaether |
CA942670A (en) * | 1969-07-28 | 1974-02-26 | Richard A. Edgren | Contraceptive compositions |
ZA81348B (en) * | 1980-01-30 | 1982-02-24 | Akzo Nv | Novel 17-amino-16-hydroxy steroids of the androstane and oestrane series and derivatives thereof,processes for their preparation and pharmaceutical compositions |
US4330540A (en) * | 1981-01-29 | 1982-05-18 | Akzo N.V. | Ent-16-amino-17-hydroxy-oestra-1,3,5(10)-trienes and derivatives thereof, and pharmaceutical compositions |
DE3263877D1 (en) * | 1981-07-07 | 1985-07-04 | Akzo Nv | Process for the selective reduction of a 14, 17-dioxo-8,4-seco-steroid |
FR2717690B1 (fr) * | 1994-03-24 | 1996-04-26 | Roussel Uclaf | Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine. |
FR2718138B1 (fr) * | 1994-04-01 | 1996-04-26 | Roussel Uclaf | Nouveaux stéroïdes comportant en position 20 une chaîne aminosubstituée, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les renfermant. |
-
1999
- 1999-04-15 DE DE19917930A patent/DE19917930A1/de not_active Withdrawn
-
2000
- 2000-04-14 PE PE2000000346A patent/PE20010042A1/es not_active Application Discontinuation
- 2000-04-14 CO CO00027851A patent/CO5180552A1/es not_active Application Discontinuation
- 2000-04-14 AR ARP000101739A patent/AR023497A1/es not_active Application Discontinuation
- 2000-04-17 DE DE60025817T patent/DE60025817T2/de not_active Expired - Fee Related
- 2000-04-17 JP JP2000612318A patent/JP2002542255A/ja active Pending
- 2000-04-17 AU AU44011/00A patent/AU4401100A/en not_active Abandoned
- 2000-04-17 ES ES00925219T patent/ES2258005T3/es not_active Expired - Lifetime
- 2000-04-17 AT AT00925219T patent/ATE316978T1/de not_active IP Right Cessation
- 2000-04-17 CA CA002371972A patent/CA2371972A1/en not_active Abandoned
- 2000-04-17 WO PCT/EP2000/003470 patent/WO2000063228A1/en active IP Right Grant
- 2000-04-17 EP EP00925219A patent/EP1169336B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2002542255A (ja) | 2002-12-10 |
AR023497A1 (es) | 2002-09-04 |
WO2000063228A1 (en) | 2000-10-26 |
CA2371972A1 (en) | 2000-10-26 |
AU4401100A (en) | 2000-11-02 |
EP1169336B1 (de) | 2006-02-01 |
DE19917930A1 (de) | 2000-10-19 |
ES2258005T3 (es) | 2006-08-16 |
PE20010042A1 (es) | 2001-02-15 |
EP1169336A1 (de) | 2002-01-09 |
DE60025817T2 (de) | 2006-11-02 |
DE60025817D1 (de) | 2006-04-13 |
CO5180552A1 (es) | 2002-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE316978T1 (de) | Ent-steroide als selektiv wirksame estrogene | |
ATE339417T1 (de) | Biphenyl - sulfonamide als duale angiotensin - endothelin - rezeptor - antagonisten | |
IS6120A (is) | Lyfjablanda | |
DE50012282D1 (de) | Sonnendach | |
DE122007000064I2 (de) | Erythropoietinkonjugate | |
DE19983871T1 (de) | Fönvorrichtung | |
DE10084676T1 (de) | Einmallanzettvorrichtung | |
ATA51899A (de) | Handstempel | |
DE60134094D1 (de) | C7-taxanester als antitumormittel | |
DE60008638D1 (de) | Förderbandabstreicher | |
ATE357433T1 (de) | 4-pyrimidinyl-n-acyl-l-phenylanine | |
PT1218009E (pt) | Grandulos de quetiapina | |
ATE297895T1 (de) | 4-pyridinyl-n-acyl-l-phenylalanine | |
DE60044218D1 (de) | em | |
PT1218096E (pt) | Microcapsulas de libertacao variavel | |
DE69943245D1 (de) | Gaserzeugende zusammensetzung | |
ATE313553T1 (de) | 16-hydroxyestratriene als selektiv wirksame estrogene | |
PT1163256E (pt) | Hemi-hidrato de 16-alfa-bromoepiandrosterona | |
DE60003072D1 (de) | Thiazolidindion-derivate als antidiabetika | |
PT1235566E (pt) | Formulacao injectavel de valnemulina | |
DE10085008T1 (de) | Oberflächenbehandlungsdüse | |
DE60020682D1 (de) | Resorcinenthaltende zusammensetzung | |
DE10018423B8 (de) | Schiebedach | |
ID27329A (id) | Komposisi penghambat | |
DE10082008D2 (de) | Ausbeulgerät |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1169336 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |